Article
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy.
Molecular cancer therapeutics - 1 Apr 2008
Gilbert Judith A, Goetz Matthew P, Reynolds Carol A, Ingle James N, Giordano Karin F, Suman Vera J, Blair Hilary E, Jenkins Robert B, Lingle Wilma L, Reinholz Monica M, Adjei Alex A, Ames Matthew M
Abstract excerpt
Metaplastic breast carcinoma, a rare tumor composed of adenocarcinomatous and nonglandular growth patterns, is characterized by a propensity for distant metastases and resistance to standard anticancer therapies. We sought confirmation that this tumor is a basal-like breast cancer, expressing epidermal growth factor receptor (EGFR) and stem cell factor receptor (KIT). EGFR activating mutations and high copy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
